TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
54 hedge funds and large institutions have $50.6M invested in Tourmaline Bio in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 6.43% → 6.46% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
54
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.18M | |
| 2 | +$1.4M | |
| 3 | +$967K | |
| 4 |
Morgan Stanley
New York
|
+$431K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$210K |
Top Sellers
| 1 | -$4.09M | |
| 2 | -$1.9M | |
| 3 | -$127K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$92K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$89K |